Table 1.
Parameters | Expression of NR_109 in TAMs | P value | |
GC | Low (%) | High (%) | |
Age/year | 0.694 | ||
<60 | 3 (30) | 7 (70) | |
≥60 | 9 (45) | 11 (55) | |
Gender | 0.024* | ||
Male | 12 (52) | 11 (48) | |
Female | 0 (0) | 7 (100) | |
Grade | 0.669 | ||
Ⅰ–Ⅱ | 10 (43) | 13 (57) | |
Ⅲ | 2 (29) | 5 (71) | |
Tumor size | 0.711 | ||
≤5 cm | 6 (46) | 7 (54) | |
>5 cm | 6 (35) | 11 (65) | |
Lymph node | 0.045* | ||
No | 7 (70) | 3 (30) | |
Yes | 5 (25) | 15 (75) | |
TNM stage | 1.000 | ||
Ⅰ–Ⅱ | 6 (40) | 9 (60) | |
Ⅲ–IV | 6 (40) | 9 (60) | |
BC | |||
Age/year | 0.882 | ||
≤70 | 21 (48) | 23 (52) | |
>70 | 7 (50) | 7 (50) | |
Grade | 0.786 | ||
Ⅰ–Ⅱ | 15 (50) | 15 (50) | |
Ⅲ | 13 (46) | 15 (54) | |
Tumor size | 1.000 | ||
≤4 cm | 25 (49) | 26 (51) | |
>4 cm | 3 (43) | 4 (57) | |
Lymph node | 0.754 | ||
No | 17 (50) | 17 (50) | |
Yes | 11 (46) | 13 (54) | |
TNM stage | 0.036* | ||
Ⅰ–Ⅱ | 23 (58) | 17 (42) | |
Ⅲ–IV | 5 (28) | 13 (72) |
The χ2-tests were used. *The values had statistically significant differences.
*The values had statistically significant differences.
BC, breast cancer; GC, gastric cancer; TAMs, tumor-associated macrophages.